Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. A view from above a wind turbine with two engineers standing on top of it

    Partner to scale: How international collaboration can enable the green transition

    Scaling clean industrial technologies requires a shift from fragmented national strategies to targeted, durable international cooperation.
  2. Three EU flags outside a large glass and steel building in Brussels, Belgium

    The Europe agenda: Trade and integration

    This briefing note explores the options for the UK to deepen the trading relationship and sets out a proposed path forward.

  3. Brexit 10 years on: Time the North took back control through devolution

    Why does 'take back control' not extend to devolution?